SELLAS Life Sciences Group Inc (SLS)
followers
·
Follow
Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Angelos M. Stergiou
Employees:
10
7 TIMES SQUARE, SUITE 2503, NEW YORK, NY, 10036
6462005278
-
Formally known as:
- Galena Biopharma, Inc.
- RXi Pharmaceuticals Corporation
Are you looking for this stock instead?
| Date | Ratio |
|---|---|
| 2016-11-14 | 1:20 |
| 2018-01-02 | 1:30 |
| 2019-11-08 | 1:50 |
SELLAS Life Sciences Group, Inc. focuses on the development of novel cancer immunotherapies for various cancer indications in the United States. Its lead product candidate is galinpepimut-S (GPS), a cancer immunotherapy that targets Wilms tumor 1, which is in Phase III clinical trials for the treatment of acute myeloid leukemia; and in Phase 1/2 clinical trials. The company was founded in 2012 and is headquartered in New York, New York.
| All 13F Filers | Prior | Change | Hedge Funds 1 | Prior | Change |
|---|